These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 27936215)
1. Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells. PLOS ONE Staff PLoS One; 2016; 11(12):e0168429. PubMed ID: 27936215 [TBL] [Abstract][Full Text] [Related]
2. Correction: RBPJ, the Major Transcriptional Effector of Notch Signaling, Remains Associated with Chromatin throughout Mitosis, Suggesting a Role in Mitotic Bookmarking. PLOS Genetics Staff PLoS Genet; 2016 Jul; 12(7):e1006209. PubMed ID: 27427944 [TBL] [Abstract][Full Text] [Related]
3. Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo. El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR PLoS One; 2018; 13(11):e0206953. PubMed ID: 30383871 [TBL] [Abstract][Full Text] [Related]
4. Correction: Notch Ligand Delta-Like 4-Pretreated Dendritic Cells Alleviate Allergic Airway Responses by Enhancing IL-10 Production. Huang HM; Hsiao G; Fan CK; Lin CL; Leu SJ; Chiang BL; Lee YL PLoS One; 2017; 12(10):e0186529. PubMed ID: 29020050 [TBL] [Abstract][Full Text] [Related]
5. Correction: Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae. Kristian SA; Ota T; Bubeck SS; Cho R; Groff BC; Kubota T; Destito G; Martin C; Laudenslager J; Koriazova L; Tahara T; Kanda Y PLoS One; 2017; 12(2):e0171732. PubMed ID: 28166258 [TBL] [Abstract][Full Text] [Related]
6. Correction: Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. Palatnik A; Ye S; Kendziorski C; Iden M; Zigman JS; Hessner MJ; Rader JS PLoS One; 2018; 13(2):e0193687. PubMed ID: 29474459 [TBL] [Abstract][Full Text] [Related]
8. Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake. PLOS ONE Staff PLoS One; 2016; 11(5):e0155168. PubMed ID: 28886011 [TBL] [Abstract][Full Text] [Related]
9. Correction: Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells. Goudin N; Chappert P; Mégret J; Gross DA; Rocha B; Azogui O PLoS One; 2017; 12(1):e0171373. PubMed ID: 28129385 [TBL] [Abstract][Full Text] [Related]
10. Correction: Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell. Ferdous F; Saski C; Bridges W; Burns M; Dunn H; Elliott K; Scott TR PLoS One; 2019; 14(4):e0214895. PubMed ID: 30934026 [TBL] [Abstract][Full Text] [Related]
11. Correction: Biologically anchored knowledge expansion approach uncovers KLF4 as a novel insulin signaling regulator. Muthiah A; Angulo MS; Walker NN; Keller SR; Lee JK PLoS One; 2018; 13(11):e0207325. PubMed ID: 30403750 [TBL] [Abstract][Full Text] [Related]
12. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLOS ONE Staff PLoS One; 2017; 12(3):e0174493. PubMed ID: 28301577 [TBL] [Abstract][Full Text] [Related]
13. Correction: Psychological Well-Being and the Human Conserved Transcriptional Response to Adversity. Fredrickson BL; Grewen KM; Algoe SB; Firestine AM; Arevalo JM; Ma J; Cole SW PLoS One; 2016; 11(6):e0157116. PubMed ID: 27257887 [TBL] [Abstract][Full Text] [Related]
14. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer. PLOS ONE Staff PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883 [TBL] [Abstract][Full Text] [Related]
15. Correction: Impact of Heat Stress on Cellular and Transcriptional Adaptation of Mammary Epithelial Cells in Riverine Buffalo (Bubalus Bubalis). Kapila N; Sharma A; Kishore A; Sodhi M; Tripathi PK; Mohanty AK; Mukesh M PLoS One; 2018; 13(1):e0191380. PubMed ID: 29324889 [TBL] [Abstract][Full Text] [Related]
16. Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. Dotan I; Roche PJ; Tamilia M; Paliouras M; Mitmaker EJ; Trifiro MA PLoS One; 2016; 11(6):e0158022. PubMed ID: 27309538 [TBL] [Abstract][Full Text] [Related]
17. Correction: The promoter region of lapA and its transcriptional regulation by Fis in Pseudomonas putida. Ainelo H; Lahesaare A; Teppo A; Kivisaar M; Teras R PLoS One; 2018; 13(1):e0192336. PubMed ID: 29381767 [TBL] [Abstract][Full Text] [Related]
18. Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling. Seth C; Ruiz I Altaba A PLoS One; 2016; 11(8):e0160904. PubMed ID: 27489960 [TBL] [Abstract][Full Text] [Related]
19. Correction: Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on β-Catenin·Tcf-4 Transcriptional Activity. Raurell I; Codina M; Casagolda D; Del Valle B; Baulida J; de Herreros AG; Duñach M PLoS One; 2016; 11(8):e0161515. PubMed ID: 27525417 [TBL] [Abstract][Full Text] [Related]
20. Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis. PLOS ONE Staff PLoS One; 2019; 14(10):e0223429. PubMed ID: 31600249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]